Forte Biosciences, Inc. (TOCA) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Net income	-13.9	-21.7	-46.5	-4.1	-49.0	-38.9	-33.5	-23.1
Depreciation and amortization [+]			0.1	0.0	0.6	0.3	0.3	0.2
Depreciation			0.1	0.0	0.6	0.3	0.3	0.2
Stock-based compensation			1.0	0.0	6.9	4.5	1.3	1.1
Change in working capital [+]	2.6	3.8	-3.8	1.3	5.2	2.6	2.0	0.7
Other current assets			-0.3	0.0	-0.2	-0.7	-0.2	-1.1
Accounts payable			-0.4	1.0	1.3	0.3	0.6	0.6
Accrued expenses			-3.2	0.3	4.1	2.9	1.5	1.3
Deferred revenues								-0.1
Other	2.6	3.8
Other operating activities	3.1	1.2	30.9		1.8	0.5	0.4	0.0
Cash from operations	-8.2	-16.7	-18.4	-2.8	-34.5	-31.1	-29.5	-21.0

Capital expenditures [+]	0.0	0.0	0.0	-0.2	-2.0	-0.7	-0.5	-0.2
Purchases of property and equipment				-0.2	-2.0	-0.7	-0.5	-0.2
Sales of property and equipment						0.0		0.0
Purchases of short-term investments, net					-2.2	-27.1	25.1	-24.7
Purchases of short-term investments					-70.7	-70.8	-23.0	-59.9
Sales of short-term investments					68.5	43.7	48.1	35.2
Other cash from investing			3.6
Cash from investing	0.0	0.0	3.6	-0.2	-4.2	-27.7	24.6	-24.9

Issuance of common stock, net	7.2		66.7		0.7	0.5	0.0	0.2
Option exercises			0.3
Financing costs			-0.3
Other cash from financing	0.0	0.0	-0.1	4.9	42.9	88.8	2.3	49.8
Cash from financing	7.2	0.0	66.7	4.9	43.5	89.3	2.3	49.9

Free cash flow	-8.2	-16.7	-18.4	-2.9	-36.4	-31.8	-30.1	-21.3
Per share (diluted)	($0.47)	($1.19)	($2.50)	($1.39)	($1.82)	($2.18)	($13.67)	($9.75)

Cash paid for interest					1.5	1.2	1.5	0.1